FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to cosmetology and represents a composition adapted for oral administration, able to provide an anti-ageing skin effect, and containing the PPAR ligand containing omega-3 fatty acid specified in DHA, EPA or mixtures thereof, an agent binding to an oestrogen receptor, containing soya isoflavones, taking part in the post-translation collagen modification, representing vitamin C and a carotinoid; the composition contains one or more additional ingredients specified in antioxidants, flavouring agents, preserving agents and stabilising agents; the composition is substantially free from zinc and/or selenium, the composition is presented in the form of a capsule; provided the composition contains at least 0.01 wt % edible phospholipid emulsifying agents, a total amount of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) in the composition makes more than 0.6 wt % or less than 0.024 wt %.
EFFECT: invention provides the synergetic effect on procollagen I, thereby ensuring the better positive anti-ageing skin effect.
13 cl, 2 ex, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
PERORAL COMPOSITION WITH EFFECT AIMED AGAINST SKIN AGING | 2007 |
|
RU2434642C2 |
ORAL COMPOSITION FOR SKIN IMPROVEMENT | 2005 |
|
RU2396073C2 |
METHODS OF LIFE QUALITY OF OLD ANIMALS IMPROVEMENT | 2005 |
|
RU2367195C2 |
COMPOSITIONS SUITABLE TO TREAT DERMAL SIGNS OF AGING | 2005 |
|
RU2409290C2 |
CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | 2010 |
|
RU2755902C2 |
FOOD PRODUCT FOR DIABETICS | 2005 |
|
RU2380983C2 |
COMBINATION OF LYCOPENE, POLYPHENOL AND VITAMINS FOR CARE OF KERATIN MATERIALS | 2009 |
|
RU2517132C2 |
NUTRICEUTICAL OPHTHALMOLOGICAL COMPOSITION FOR TREATMENT OF RETINAL PATHOLOGIES WITH A NEOVASCULAR COMPONENT | 2019 |
|
RU2806096C2 |
CONCENTRATED THERAPEUTIC PHOSPHOLIPIDE COMPOSITIONS | 2010 |
|
RU2642653C2 |
BALL-SHAPED LIPOIC ACID COMPOSITION | 2008 |
|
RU2501558C2 |
Authors
Dates
2014-11-20—Published
2010-05-20—Filed